23-1405 New CMS HCPCS Codes and Prior Authorization Changes
Date: 11/29/23
Palliative care requires prior authorization for D-SNP members starting January 1, 2024
Wellcare By Health Net (Health Net) is making changes to the Medicare Advantage HMO/PPO prior authorization (PA) requirements as outlined in the table below. These changes apply to Direct Network physicians, hospitals, ancillary providers, and non-delegated fee-for-service participating physician groups.
For members who are dually eligible (Medi-Cal secondary coverage), services covered under their Medicare plan follow Medicare authorization requirements. Services that are only covered under the member’s Medi-Cal benefits should follow the member’s Medi-Cal authorization requirements.
Effective October 1, 2023
The below Part B medications require PA per new HCPCS codes issued by the Centers for Medicare & Medicaid Services.
Code | Description | Brand/reference |
---|---|---|
C9155 | Injection, epcoritamab-bysp, 0.16 mg | EpkinlyTM |
C9157 | Injection, tofersen, 1 mg | QalsodyTM |
J0801 | Injection, corticotropin (Acthar Gel), up to 40 units | HP Acthar® |
J0802 | Injection, corticotropin (ANI), up to | Cortrophin® |
J0889 | Daprodustat, oral, 1 mg, (for ESRD | JesduvroqTM |
J2781 | Injection, pegcetacoplan, intravitreal, | Syfovre® |
J7214 | Injection, Factor VIII/von Willebrand factor complex, recombinant (Altuviiio), per Factor VIII IU | Hemophilia factors: AltuviiioTM |
J9051 | Injection, bortezomib (MAIA), not therapeutically equivalent to J9041, 0.1 mg | Velcade® |
J9064 | Injection, cabazitaxel (Sandoz), not therapeutically equivalent to J9043, 1 mg | generic for Jevtana® |
J9345 | Injection, retifanlimab-dlwr, 1 mg | ZynyzTM |
Outpatient pharmaceuticals (submitted under Medical Benefit)
Medication newly approved by the U.S. Food and Drug Administration (FDA) requires PA, effective immediately.
Requirement | Comments |
---|---|
ElevidysTM | delandistrogene moxeparvovec-rokl |
PA Additions, effective January 1, 2024
View the table below for PA requirement changes for Medicare Advantage HMO/PPO physicians and other providers.
Outpatient Procedures, Services or Equipment
Requirement | Comments |
---|---|
Palliative care | Applies to D-SNP members only. |
Additional information
If you have questions regarding the information contained in this update, contact the Provider Services Center at
800-929-9224.
This information applies to Physicians, Participating Physician Groups (PPGs), Hospitals, and Ancillary providers.